RetinalGenix Technologies reported net income of -$0.31M for the quarter ended Jun 2026. This income statement covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | |||||||||||||||||||||||
| Research & DevelopmentR&D | 0.20M | 0.18M | 0.16M | 0.14M | 0.20M | 0.32M | 0.23M | 0.15M | 0.09M | 0.05M | 0.08M | 0.08M | 0.10M | 0.10M | 0.01M | 0.01M | 0.02M | 0.03M | 0.12M | 0.07M | |||
| Selling, General & AdministrativeSG&A | 0.29M | 0.17M | 0.16M | 0.17M | 0.20M | 0.28M | 0.20M | 0.12M | 0.17M | 0.41M | 0.33M | 0.37M | 0.24M | 0.39M | 0.34M | 0.38M | 0.27M | 0.31M | 0.26M | 0.21M | |||
| Other Operating ExpensesOther Opex | 0.06M | 0.06M | 0.06M | 0.06M | 2.10M | 0.08M | 0.08M | 0.08M | 0.43M | 0.08M | 1.73M | 0.21M | 0.30M | 0.37M | 0.23M | 0.25M | 0.28M | 0.28M | 0.21M | 0.02M | |||
| Operating ExpensesOpex | 0.55M | 0.41M | 0.37M | 0.36M | 2.50M | 0.67M | 0.51M | 0.35M | 0.69M | 0.54M | 2.14M | 0.66M | 0.64M | 0.87M | 0.59M | 0.65M | 0.57M | 0.62M | 0.59M | 0.30M | |||
| Non-operating items | |||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 909.00 | 0.00M | 958.00 | 0.00M | 0.00M | 0.00M | |||
| Net income details | |||||||||||||||||||||||
| Profit After TaxPAT | -0.55M | -0.41M | -0.38M | -0.36M | -2.50M | -0.67M | -0.51M | -0.35M | -0.69M | -0.54M | -2.15M | -0.66M | -0.64M | -0.87M | -0.59M | -0.65M | -0.57M | -0.62M | -0.59M | -0.31M | |||
| Additional items | |||||||||||||||||||||||
| Shares Outstanding | 41.83M | 41.25M | 14.28M | 14.52M | 16.56M | 15.58M | 17.27M | 17.27M | 17.28M | 17.35M | 17.67M | 17.86M | 17.97M | 17.94M | 18.52M | 18.33M | 18.58M | 18.56M | 18.75M | 18.81M | |||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 14.52M | 16.56M | 15.58M | 17.27M | 17.27M | 17.28M | 17.35M | 17.67M | 17.86M | 17.97M | 17.94M | 18.52M | 18.33M | 18.58M | 18.56M | 18.75M | 18.81M | ||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 41.93M | 41.25M | 14.28M | 14.64M | 16.69M | 17.27M | 17.27M | 17.27M | 17.59M | 17.64M | 17.86M | 17.92M | 18.06M | 18.52M | 18.52M | 18.56M | 18.60M | 18.75M | 18.75M | 18.84M | |||
| Interest ExpensesInt Expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 960.00 | 909.00 | 0.00M | 958.00 | 0.00M | 0.00M | 0.00M |